Header cover image
  • Investing Ideas
  • /
  • Australian Pharmaceuticals & Biotech Undervalued based on future growth

Australian Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Clinuvel Pharmaceuticals

Market Cap: AU$607.4m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

CUV

AU$12.10

7D

-5.1%

1Y

3.5%